Advancing the frontiers of clinical drug development

CHDR is an independent institute specialising in innovative early-stage clinical drug research.

Our Story Our Unit

More

Gert-Jan Hassing successfully defends his PhD thesis titled ‘Feasibility of inte...

26 Apr 2024

The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in...

20 Mar 2024

Combining innovative methods with state-of-the-art facilities maximises our clients' chance of success

Gaining insight into the PK and PD of drugs that act on targets in the central nervous system

Innovative tools for studying inflammation in healthy subjects

Answering key questions in drug development by providing information regarding successful target binding